Zhejiang Medicine to hold 2024 performance briefing

Zhejiang Medicine Co., Ltd. announced that it will hold a performance briefing on May 20, 2025, from 9:30 to 10:30, to provide investors with a comprehensive understanding of the company’s 2024 operating results and financial condition. The briefing will be conducted via video and online interaction through the Shanghai Stock Exchange Roadshow Center. Investors can submit questions online from May 13 to May 19, 2025, via the Shanghai Stock Exchange Roadshow Center website or by emailing board@zmc-china.com. Key company representatives, including Chairman Wang Hongwei, Independent Director Qiu Yizheng, CFO Li Qirong, and Board Secretary Shao Minzhi, will attend. A recording of the briefing will be available on the Shanghai Stock Exchange Roadshow Center website following the event.